Poster 10
- Kelley Tangredi
- Jun 9, 2024
- 1 min read
Updated: Jun 27, 2024
Pooled patient-reported outcomes from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials of deuruxolitinib in adult patients with moderate-to-severe alopecia areata
Authors: Natasha A. Mesinkovska; Maryanne Makredes Senna; Brett King; Arash Mostaghimi; Colleen Hamilton; James Cassella

Poster 10